Addressing Concerns for Successful Implementation of National Health Insurance in South Africa

By Staff Writer

May 10, 2023

Addressing Concerns for Successful Implementation of National Health Insurance in South Africa: Perspectives from Policymakers and the Role of Pharmacists in Primary Healthcare Re-engineering

In this study, policymakers in South Africa were interviewed to gain insights into their perspectives on the implementation of National Health Insurance (NHI) and the role of pharmacists in primary healthcare (PHC) re-engineering.

The study identified several concerns that could compromise the efficient functionality of NHI and attaining universal healthcare (UHC). These concerns included the need for appropriate governance and regulatory mechanisms, the complexity of issues experienced at local levels of care, the involvement of private healthcare providers and the lack of reimbursement mechanisms, the need for stakeholder engagement and communication, and the underutilization of pharmacists in the healthcare system. The study highlights the importance of proactive and positive engagement with key role-players to address these concerns and ensure the successful implementation of NHI and PHC re-engineering in South Africa.

Reference url

Recent Posts

Guiding the Future of Digital Cardiac Rehabilitation: NICE’s Conditional Recommendations

By João L. Carapinha

August 20, 2025

The National Institute for Health and Care Excellence (NICE) has issued consultative draft guidance recommending six digital cardiac rehabilitation technologies for adults with cardiovascular disease (CVD). These technologies are conditionally recommended for use in the NHS during a three-year ev...
Assessment of Glofitamab With Gemcitabine in DLBCL Reveals No Additional Benefit

By João L. Carapinha

August 19, 2025

A recent G-BA decision provides a systematic evaluation of Glofitamab Gemcitabine DLBCL, combined with Gemcitabine and Oxaliplatin (GemOx), for treating adults with relapsed or refractory diffuse large B-cell lymphoma (DLBCL) who are ineligible for autologous stem cell transplantation. The review...
Key Decisions on Health Technology Assessment at ACP124: Implications for Rare Disease Therapies
Health technology assessment (HTA) plays a crucial role in determining whether new therapies are reimbursed within healthcare systems. At the July 18, 2025 meeting of the Adviescommissie Pakket (ACP), two high-profile orphan drugs—omaveloxolone (Skyclarys®) for Friedreich’s ataxia and exagamgloge...